5-HT3 receptor antagonist
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for 5-HT3 receptor antagonist, covering 2020-06-12 to 2025-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV [Phase 3]